Cue Biopharma Inc
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
13.27
0.36
(2.789%)
Volume:
166,738
52 week range:
9.65 - 17.23
Market Cap:
418.116M
Company Description:
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company's proprietary platform, Immuno-STAT ™(Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation.